Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
stocklegend's Profile
Displaying 801-850 of 1641 result(s).
PMCB PharmaCyte Biotech Inc.
03/26/2014 9:05:13 AM
$NVLX – Nuvilex's Medical Marijua
PMCB PharmaCyte Biotech Inc.
03/25/2014 12:47:08 PM
$NVLX CNN Discusses Medical
PMCB PharmaCyte Biotech Inc.
03/25/2014 12:36:01 PM
$NVLX Nuvilex’s Dr. Mark Rab
PMCB PharmaCyte Biotech Inc.
03/25/2014 12:34:37 PM
$NVLX Nuvilex Technology Fea
PMCB PharmaCyte Biotech Inc.
03/25/2014 12:33:19 PM
$NVLX Nuvilex’s Cell in a Bo
PMCB PharmaCyte Biotech Inc.
03/25/2014 11:02:39 AM
$NVLX Nuvilex Has Deal in Pl
PMCB PharmaCyte Biotech Inc.
03/25/2014 10:12:45 AM
$NVLX Nuvilex Prepares for L
PMCB PharmaCyte Biotech Inc.
03/25/2014 9:25:50 AM
$NVLX Nuvilex Signs Deal wit
PMCB PharmaCyte Biotech Inc.
03/25/2014 9:21:57 AM
NVLX news: 
PMCB PharmaCyte Biotech Inc.
03/25/2014 8:59:17 AM
$NVLX - Nuvilex Enters Most Importa
PMCB PharmaCyte Biotech Inc.
03/24/2014 2:07:16 PM
$NVLX Nuvilex Has Deal in Pl
PMCB PharmaCyte Biotech Inc.
03/24/2014 1:49:47 PM
$NVLX Nuvilex’s Cell in a Bo
PMCB PharmaCyte Biotech Inc.
03/24/2014 1:09:54 PM
$NVLX Nuvilex Technology Fea
PMCB PharmaCyte Biotech Inc.
03/24/2014 12:50:55 PM
$NVLX CNN Discusses Medical
PMCB PharmaCyte Biotech Inc.
03/24/2014 11:53:40 AM
$NVLX with Funding in Place,
PMCB PharmaCyte Biotech Inc.
03/24/2014 11:08:55 AM
$NVLX Nuvilex Has Funding in
PMCB PharmaCyte Biotech Inc.
03/24/2014 9:36:04 AM
$NVLX Nuvilex Continues to B
PMCB PharmaCyte Biotech Inc.
03/24/2014 8:54:47 AM
$NVLX – Nuvilex's Medical Marijua
PMCB PharmaCyte Biotech Inc.
03/21/2014 3:31:31 PM
$NVLX – Nuvilex Accelerates Devel
PMCB PharmaCyte Biotech Inc.
03/21/2014 2:50:27 PM
$NVLX – Nuvilex's Acquisition of
PMCB PharmaCyte Biotech Inc.
03/21/2014 1:30:53 PM
$NVLX – Investors Confidently Bac
PMCB PharmaCyte Biotech Inc.
03/21/2014 12:32:45 PM
$NVLX – Diabetes Treatment Drives
PMCB PharmaCyte Biotech Inc.
03/21/2014 11:24:48 AM
$NVLX – After Pancreatic Cancer,
PMCB PharmaCyte Biotech Inc.
03/21/2014 10:28:42 AM
$NVLX – Nuvilex and Eli Lilly Goi
PMCB PharmaCyte Biotech Inc.
03/21/2014 9:50:37 AM
$NVLX – Nuvilex Appoints Dr. Mark
PMCB PharmaCyte Biotech Inc.
03/21/2014 9:25:41 AM
$NVLX – Nuvilex Begins Making Mo
PMCB PharmaCyte Biotech Inc.
03/21/2014 8:59:03 AM
$NVLX – Nuvilex's Medical Marijua
PMCB PharmaCyte Biotech Inc.
03/20/2014 2:27:43 PM
NVLX Pancreatic Cancer Treatment:
PMCB PharmaCyte Biotech Inc.
03/20/2014 2:10:30 PM
$NVLX - Nuvilex Featured in Forbes
PMCB PharmaCyte Biotech Inc.
03/20/2014 1:37:47 PM
$NVLX - Nuvilex Acquires Cancer Cel
PMCB PharmaCyte Biotech Inc.
03/20/2014 1:02:49 PM
$NVLX - Nuvilex Acquires Cancer Tec
PMCB PharmaCyte Biotech Inc.
03/20/2014 12:24:56 PM
$NVLX - Nuvilex Restructures its Op
PMCB PharmaCyte Biotech Inc.
03/20/2014 10:58:58 AM
$NVLX - Nuvilex Restructures to Foc
PMCB PharmaCyte Biotech Inc.
03/20/2014 9:59:56 AM
$NVLX - Nuvilex Contracts with Inno
PMCB PharmaCyte Biotech Inc.
03/20/2014 9:13:11 AM
Big NVLX news CELL IN A BOX TECHNOL
PMCB PharmaCyte Biotech Inc.
03/20/2014 9:00:36 AM
$NVLX - Nuvilex Enters Most Importa
PMCB PharmaCyte Biotech Inc.
03/19/2014 3:28:24 PM
$NVLX – Nuvilex's Acquisition of
PMCB PharmaCyte Biotech Inc.
03/19/2014 2:30:04 PM
$NVLX – Investors Confidently Bac
PMCB PharmaCyte Biotech Inc.
03/19/2014 1:29:06 PM
$NVLX – Diabetes Treatment Drives
PMCB PharmaCyte Biotech Inc.
03/19/2014 12:06:35 PM
$NVLX – After Pancreatic Cancer,
PMCB PharmaCyte Biotech Inc.
03/19/2014 11:01:58 AM
$NVLX – Nuvilex and Eli Lilly Goi
PMCB PharmaCyte Biotech Inc.
03/19/2014 9:49:58 AM
$NVLX – Nuvilex Appoints Dr. Mark
PMCB PharmaCyte Biotech Inc.
03/19/2014 9:17:10 AM
$NVLX – Nuvilex Begins Making Mov
PMCB PharmaCyte Biotech Inc.
03/19/2014 9:12:44 AM
$NVLX – Nuvilex's Medical Marijua
PMCB PharmaCyte Biotech Inc.
03/18/2014 3:12:40 PM
$NVLX – Nuvilex Listed in Forbes
PMCB PharmaCyte Biotech Inc.
03/18/2014 1:53:38 PM
$NVLX - Nuvilex COO Talks Medical M
PMCB PharmaCyte Biotech Inc.
03/18/2014 12:55:49 PM
$NVLX - Nuvilex Featured in Forbes
PMCB PharmaCyte Biotech Inc.
03/18/2014 12:14:36 PM
$NVLX - Nuvilex Acquires Cancer Cel
PMCB PharmaCyte Biotech Inc.
03/18/2014 11:09:57 AM
$NVLX - Nuvilex Acquires Cancer Tec
PMCB PharmaCyte Biotech Inc.
03/18/2014 10:18:43 AM
$NVLX - Nuvilex Restructures its Op
Go to page:
  • << First
  • < Previous
  • 16
  • 17
  • Next >

Recent Articles

  • Dodge Charger Daytona: Power and Innovation Earn Awards
  • Hyundai IONIQ 5 & 6 Triumph as Top EV Choices for 2026
  • C1 Strengthens Leadership Team with New Executive Appointments
  • FirstEnergy Foundation Boosts Hunger Relief with Major Grant
  • Park Street Homes Champions Urban Affordability Revolution
  • Genstore's Transformative AI-native Platform Gains $10 Million
  • SoundHound AI's Breakthrough Partnership Boosts Stock Prices
  • Celebrating Educational Excellence: Ferrellgas Scholarship Winners
  • LifeMD Faces Securities Fraud Concerns: Investor Insights
  • Examining Oklo's Transition to Nuclear Energy Profits
  • Investors Alert: PubMatic Faces Class Action Over Stock Drop
  • G2S2 Capital Expands Its Portfolio with First Tower Acquisition
  • Understanding Market Trends Related to Haemonetics Stock
  • Understanding Allstate's Market Sentiment: Bullish or Bearish?
  • Explore Innovative Screen Protectors by Screen Skinz for iPhone 17
  • Aroma360 and Hotel Collection Take Legal Action Against Scentiment
  • Experience the Vibrant Return of FUZE Caribbean Art Fair
  • Revolutionizing Footwear with DURAPONTEX® L-TAC Foam Technology
  • Honoring Loved Ones: The Judah Style Figure Display Concept
  • SWIRL AI Warehouse Revolutionizes Data Analytics and Business Intelligence
  • Thompson Safety's Strategic Growth: Kartman Fire Acquisition
  • EPH European Property Holdings PLC Reports Interim Results for 2025
  • Investor Insights on Potential Legal Actions for Shareholders
  • Klépierre Launches €500M Green Bond to Support Sustainability
  • Vishay Ametherm's New Thermistor Achieves Key Certification
  • Eric Perakslis Joins Shotsy as Chief Science Officer for Innovation
  • Reitir Initiates New Share Buyback Program for Growth
  • Bristol Myers Squibb's Promising Progress in Multiple Myeloma
  • Renault Group's Green Bond Issuance: A Sustainable Step Forward
  • Analyzing Arista Networks Inc: A Deep Dive into Valuation Insights
  • In-Depth Analysis of IBM's Recent Options Activity Trends
  • Investor Insights on Carnival Corporation's Strong Activity
  • Exploring Unusual Options Activity for Rubrik (RBRK)
  • Discover the Remarkable Growth of Dollar Tree's Stock Over Two Decades
  • EPH European Property Holdings' Strong Interim Results in 2025
  • Discover Exquisite Experiences at Four Seasons Puerto Rico
  • Nova Compression Secures $325 Million for Expansion Efforts
  • Wellesley Asset Management Expands Horizons with New Acquisition
  • Eli Lilly's Ambitious $6.5 Billion Facility to Innovate Medicine
  • Innovative Self-Defense Device Revolutionizes Personal Safety
  • Transforming Lives Through Character Strengths Assessment Tool
  • Foresight Ventures Welcomes Experienced Director to Board
  • Teradyne Inc: Navigating the Crucial Trading Crossroads
  • Exploring the Surging Stocks of the AI Boom: A Deep Dive
  • Empowering Opportunity Youth and Veterans Through Strategic Grants
  • Hunterdon Health Partners with Medline for Enhanced Care
  • Innovative Picture Frame Design Enhances Home Decor Choices
  • Revolutionizing Home Goods: Barrett and Tumble Living Team Up
  • ARS Pharmaceuticals Calls for Caution on Aquestive's Treatment Approval
  • Investigation into Shareholder Rights for Premier Inc and PROS
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site